Nuclear Medicine Market: Information by Type (Diagnostic and Therapeutic Nuclear Medicines), Applications (Oncology, Cardiology), End-users, and Region — Forecast till 2029

Mar 29, 2020   Market Overview Nuclear medicine is a multidisciplinary field that specializes in radioactive material used for diagnosing and treating various diseases in neurology, endocrine system, cardiology, gastrointestinal system, and cancers. Radiopharmaceuticals comprise of a radioactive tracer that is injected in the patient's body. Later, the gamma-rays are released in the body to display images using the Single-photon Emission Computed Tomography (SPECT) and Positron emission tomography (PET) imagi...
Request Free Sample Report

Tables and figures

LIST OF TABLES

TABLE 1       Global Nuclear Medicines Market Share, By Type, 2017–2029 (USD Million)

TABLE 2       Diagnostic Nuclear Medicines Drugs Market Share, By Region, 2017–2029 (USD Million)

TABLE 3       Therapeutic Nuclear Medicines Drugs Market Share, By Region, 2017–2029 (USD Million)

TABLE 4       Global Nuclear Medicines Market Share, By End users, 2017–2029 (USD Million)

TABLE 5       Hospitals Market Share, By Region, 2017–2029 (USD Million)

TABLE 6       Imaging centers Market Share, By Region, 2017–2029 (USD Million)

TABLE 7       Academics and research centers Market Share, By Region, 2017–2029, (USD Million)

TABLE 8       Global Nuclear Medicines Market Share Value, 2017–2029 (USD Million)

TABLE 9       America Nuclear Medicines Market Share Value, By Region, 2017–2029 (USD Million)

TABLE 10    America Nuclear Medicines Market Share value, By Type, 2017–2029 (USD Million)

TABLE 11    America Nuclear Medicines Market Share value, By End users, 2017–2029 (USD Million)

TABLE 12    North America Nuclear Medicines Market Share Value, By Country, 2017–2029 (USD Million)

TABLE 13    North America Nuclear Medicines Market Share value, By Type, 2017–2029 (USD Million)

TABLE 14    North America Nuclear Medicines Market Share value, By End users, 2017–2029 (USD Million)

TABLE 15    U.S. Nuclear Medicines Market share, By Type, 2017–2029 (USD Million)

TABLE 16    U.S. Nuclear Medicines Market share, By End users, 2017–2029 (USD Million)

TABLE 17    Canada Nuclear Medicines Market share, By Type, 2017–2029 (USD Million)

TABLE 18    Canada Nuclear Medicines Market share, By End users, 2017–2029 (USD Million)

TABLE 19    Mexico Nuclear Medicines Market share, By Type, 2017–2029 (USD Million)

TABLE 20    Mexico Nuclear Medicines Market share, By End users, 2017–2029 (USD Million)

TABLE 21    Central, South America, and Caribbean Nuclear Medicines Market share, By Country, 2017–2029 (USD Million)

TABLE 22    Central, South America, and Caribbean Nuclear Medicines Market share, By Type, 2017–2029 (USD Million)

TABLE 23    Central, South America, and Caribbean Nuclear Medicines Market share, By End users, 2017–2029 (USD Million)

TABLE 24    Brazil Nuclear Medicines Market share, By Type, 2017–2029 (USD Million)

TABLE 25    Brazil Nuclear Medicines Market share, By End users, 2017–2029 (USD Million)

TABLE 26    Argentina Nuclear Medicines Market share, By Type, 2017–2029 (USD Million)

TABLE 27    Argentina Nuclear Medicines Market share, By End users, 2017–2029 (USD Million)

TABLE 28    Rest of Central, South America, and Caribbean Nuclear Medicines Market share, By Type, 2017–2029 (USD Million)

TABLE 29    Rest of Central, South America, and Caribbean Nuclear Medicines Market share, By End users, 2017–2029 (USD Million)

TABLE 30    Europe Nuclear Medicines Market Share Value, By Region, 2017–2029 (USD Million)

TABLE 31    Europe Nuclear Medicines Market share, By Type, 2017–2029 (USD Million)

TABLE 32    Europe Nuclear Medicines Market share, By End users, 2017–2029 (USD Million)

TABLE 33    Western Europe Nuclear Medicines Market share, By Country, 2017–2029 (USD Million)

TABLE 34    Western Europe Nuclear Medicines Market share, By Type, 2017–2029 (USD Million)

TABLE 35    Western Europe Nuclear Medicines Market share, By End users, 2017–2029 (USD Million)

TABLE 36    Germany Nuclear Medicines Market share, By Type, 2017–2029 (USD Million)

TABLE 37    Germany Nuclear Medicines Market share, By End users, 2017–2029 (USD Million)

TABLE 38    France Nuclear Medicines Market share, By Type, 2017–2029 (USD Million)

TABLE 39    France Nuclear Medicines Market share, By End users, 2017–2029 (USD Million)

TABLE 40    U.K Nuclear Medicines Market share, By Type, 2017–2029 (USD Million)

TABLE 41    U.K Nuclear Medicines Market share, By End users, 2017–2029 (USD Million)

TABLE 42    Italy Nuclear Medicines Market share, By Type, 2017–2029 (USD Million)

TABLE 43    Italy Nuclear Medicines Market share, By End users, 2017–2029 (USD Million)

TABLE 44    Spain Nuclear Medicines Market share, By Type, 2017–2029 (USD Million)

TABLE 45    Spain Nuclear Medicines Market share, By End users, 2017–2029 (USD Million)

TABLE 46    Rest of Western Europe Nuclear Medicines Market share, By Type, 2017–2029 (USD Million)

TABLE 47    Rest of Western Europe Nuclear Medicines Market share, By End users, 2017–2029 (USD Million)

TABLE 48    Eastern Europe Nuclear Medicines Market share, By Type, 2017–2029 (USD Million)

TABLE 49    Eastern Europe Nuclear Medicines Market share, By End users, 2017–2029 (USD Million)

TABLE 50    Asia-Pacific Nuclear Medicines Market Share Value, By Country, 2017–2029 (USD Million)

TABLE 51    Asia-Pacific Nuclear Medicines Market share, By Type, 2017–2029 (USD Million)

TABLE 52    Asia-Pacific Nuclear Medicines Market share, By End users, 2017–2029 (USD Million)

TABLE 53    Japan Nuclear Medicines Market share, By Type, 2017–2029 (USD Million)

TABLE 54    Japan Nuclear Medicines Market share, By End users, 2017–2029 (USD Million)

TABLE 55    China Nuclear Medicines Market share, By Type, 2017–2029 (USD Million)

TABLE 56    China Nuclear Medicines Market share, By End users, 2017–2029 (USD Million)

TABLE 57    Australia Nuclear Medicines Market share, By Type, 2017–2029 (USD Million)

TABLE 58    Australia Nuclear Medicines Market share, By End users, 2017–2029 (USD Million)

TABLE 59    India Nuclear Medicines Market share, By Type, 2017–2029 (USD Million)

TABLE 60    India Nuclear Medicines Market share, By End users, 2017–2029 (USD Million)

TABLE 61    South Korea Nuclear Medicines Market share, By Type, 2017–2029 (USD Million)

TABLE 62    South Korea Nuclear Medicines Market share, By End users, 2017–2029 (USD Million)

TABLE 63    Rest of Asia-pacific Nuclear Medicines Market share, By Type, 2017–2029 (USD Million)

TABLE 64    Rest of Asia-pacific Nuclear Medicines Market share, By End users, 2017–2029 (USD Million)

TABLE 65    Middle East and Africa Nuclear Medicines Market Share Value, By Region, 2017–2029 (USD Million)

TABLE 66    Middle East and Africa Nuclear Medicines Market share, By Type, 2017–2029 (USD Million)

TABLE 67    Middle East and Africa Nuclear Medicines Market share, By End users, 2017–2029 (USD Million)

TABLE 68    Middle East Nuclear Medicines Market share, By Country, 2017–2029 (USD Million)

TABLE 69    Middle East Nuclear Medicines Market share, By Type, 2017–2029 (USD Million)

TABLE 70    Middle East Nuclear Medicines Market share, By End users, 2017–2029 (USD Million)

TABLE 71    Saudi Arabia Nuclear Medicines Market share, By Type, 2017–2029 (USD Million)

TABLE 72    Saudi Arabia Nuclear Medicines Market share, By End users, 2017–2029 (USD Million)

TABLE 73    UAE Nuclear Medicines Market share, By Type, 2017–2029 (USD Million)

TABLE 74    UAE Nuclear Medicines Market share, By End users, 2017–2029 (USD Million)

TABLE 75    Qatar Nuclear Medicines Market share, By Type, 2017–2029 (USD Million)

TABLE 76    Qatar Nuclear Medicines Market share, By End users, 2017–2029 (USD Million)

TABLE 77    Rest of Middle East Nuclear Medicines Market share, By Type, 2017–2029 (USD Million)

TABLE 78    Rest of Middle East Nuclear Medicines Market share, By End users, 2017–2029 (USD Million)

TABLE 79    Africa Nuclear Medicines Market share, By Type, 2017–2029 (USD Million)

TABLE 80    Africa Nuclear Medicines Market share, By End users, 2017–2029 (USD Million)

LIST OF FIGURES

FIGURE 1     Global Nuclear Medicines Market Overview

FIGURE 2     Value Chain Analysis

FIGURE 3     Bargaining Power of Suppliers

FIGURE 4     Bargaining Power of Buyers

FIGURE 5     Threat of Substitutes

FIGURE 6     Threat of New Entrants

FIGURE 7     Competitive Rivalry

FIGURE 8     Nuclear Medicines Market, Market Share Analysis, 2019

FIGURE 9     Global Nuclear Medicines Market, 2017-2029

FIGURE 10  U.S. Nuclear Medicines Market Share, 2017–2029 (USD Million)

FIGURE 11  Canada Nuclear Medicines Market Share, 2017–2029 (USD Million)

FIGURE 12  Mexico Nuclear Medicines Market Share, 2017–2029 (USD Million)

FIGURE 13  Western Europe Nuclear Medicines Market Share, 2017–2029 (USD Million)

FIGURE 14  Germany Nuclear Medicines Market Share, 2017–2029 (USD Million)

FIGURE 15  France Nuclear Medicines Market Share, 2017–2029 (USD Million)

FIGURE 16  U.K Nuclear Medicines Market Share, 2017–2029 (USD Million)

FIGURE 17  Italy Nuclear Medicines Market Share, 2017–2029 (USD Million)

FIGURE 18  Spain Nuclear Medicines Market Share, 2017–2029 (USD Million)

FIGURE 19  Rest of Western Europe Nuclear Medicines Market Share, 2017–2029 (USD Million)

FIGURE 20  Eastern Europe Nuclear Medicines Market Share, 2017–2029 (USD Million)

FIGURE 21  Japan Nuclear Medicines Market Share, 2017–2029 (USD Million)

FIGURE 22  China Nuclear Medicines Market Share, 2017–2029 (USD Million)

FIGURE 23  Australia Nuclear Medicines Market Share, 2017–2029 (USD Million)

FIGURE 24  India Nuclear Medicines Market Share, 2017–2029 (USD Million)

FIGURE 25  South Korea Nuclear Medicines Market Share, 2017–2029 (USD Million)

FIGURE 26  Rest of Asia-pacific Nuclear Medicines Market Share, 2017–2029 (USD Million)

FIGURE 27  Middle East Nuclear Medicines Market Share, 2017–2029 (USD Million)

FIGURE 28  Saudi Arabia Nuclear Medicines Market Share, 2017–2029 (USD Million)

FIGURE 29  UAE Nuclear Medicines Market Share, 2017–2029 (USD Million)

FIGURE 30  Qatar Nuclear Medicines Market Share, 2017–2029 (USD Million)

FIGURE 31  Rest of Middle East Nuclear Medicines Market Share, 2017–2029 (USD Million)

FIGURE 32  Africa Nuclear Medicines Market Share, 2017–2029 (USD Million)

FIGURE 33  Curium Pharma: Revenue Analysis, (USD Million)

FIGURE 34  Curium Pharma: Segment Revenue 2018 (%)